Science Current Events | Science News | Brightsurf.com
 
corner top left block corner top right

E. coli persists against antibiotics through HipA-induced dormancy

January 16, 2009

HOUSTON - Bacteria hunker down and survive antibiotic attack when a protein flips a chemical switch that throws them into a dormant state until treatment abates, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan.16 edition of Science.

"For antibiotics to work, bacteria have to be growing. Dormancy stops everything, allowing some bacteria to persist after treatment," said senior author Richard Brennan, Ph.D., professor in M. D. Anderson's Department of Biochemistry and Molecular Biology.

By demonstrating in detail how the HipA protein freezes bacterial activity, the researchers have opened the possibility of adding a new class of drugs to therapy against chronic and multidrug resistant bacterial infection.

Working in Escherichia coli, the team solved the structure of HipA and several of its protein complexes down to the atomic level, confirming that HipA is a protein kinase - an enzyme that works by transferring phosphate groups to its target molecules.

HipA is a type of protein kinase that is uncommon in bacteria, said lead author Maria Schumacher, Ph.D., associate professor of biochemistry and molecular biology. While other types of phosphorylation occur in bacteria, HipA phosphorylates proteins at their serine or threonine amino acids. This kinase activity is more commonly associated with eukaryotic cells, which make up animals, plants and fungi, and are generally thought to be more complex.

"These 'simple bacteria' are so complex. We're finding that life is sophisticated at all levels," Schumacher said. HipA is active in other types of gram-negative bacteria, which cause significant human bacterial infections.

Inhibitor could make persistent cells 'vanish'

A number of cancer drugs inhibit kinase activity in specific targets.

"If you stop HipA from working, there essentially is no persistence," Brennan said. "We need to see whether kinase inhibitors will bind to and block HipA's active site. If they work, persistent cells, which are already rare, would vanish." Persistent cells are a one-in-a-million-cells occurrence because HipA is normally kept in check by a protein called HipB.

Persistence is common in "biofilms," bacterial colonies that become attached to a surface in a supportive matrix. Drug-resistant biofilms cause about 60 percent of infections in the developed world, the researchers note.

Overexpression of HipA previously had been associated with cell dormancy and bacterial persistence. Evidence had pointed to kinase activity.

Schumacher, Brennan and colleagues demonstrated the molecular details of HipA's role in multidrug tolerance and HipB's role keeping HipA under wraps in a series of experiments:

* Using X-ray crystallography to determine and then compare the structures of several HipA complexes, they showed that HipA has a serine/threonine protein kinase fold and that it binds tightly to adenosine triphosphate (ATP), a common characteristic of kinases. Phosphorylation occurs when an enzyme binds to both ATP and to its target protein.
* Assays of candidate proteins to identify a target for HipA found that EF-Tu interacts strongly with HipA in the presence of ATP. EF-Tu is the most abundant protein in E.coli and plays an essential role in protein synthesis.
* Subsequent experiments and structural analysis of a HipA/EF-Tu peptide complex indicated that HipA phosphorylates EF-Tu, freezing up the bacteria's protein-making machinery and inducing dormancy.
* To analyze how HipB normally prevents HipA's function, the team solved the structure of the HipB/DNA/HipA complex. HipB tightly binds two HipA molecules in a sandwich-like structure.
* HipB does not block HipA's active site, but inactivates it by forcing it into an "open" position. "Proteins move a lot to function, they open and close - think of a clam shell, for example," Brennan explains. To function, a protein must be able to close down on its target molecules - called substrates. The closed state is the active state.
* HipB also might physically sequester HipA from EF-Tu because the HipA/HipB/DNA complex is located in E. coli's nucleoid, far from the bacteria's membrane where EF-Tu is mainly found.

HipA is free to cause trouble when its ties to HipB are broken; an infrequent occurrence which the authors note is likely caused by proteases tugging the smaller and structurally vulnerable HipB protein out of the complex.

Protein kinases often bind to more than one protein, so there are likely multiple targets for the protein in E. coli and other gram-negative bacteria, Schumacher and Brennan said.

Future research will focus on finding other HipA targets in E. coli, and kinase inhibitors will be examined for their ability to affect HipA function. If a promising inhibitor is found, its structure will be solved to clarify its binding mode and how it might be tweaked to bind HipA even better. "Structure-based drug design should provide the best chance at formulating highly specific and effective drugs against HipA," Schumacher said.

University of Texas M. D. Anderson Cancer Center




Kinetic assessment of persistent halogenated xenobiotics in cell culture models. Comparison of mono- and poly-halogenated compounds [An article from: Chemosphere]

Kinetic assessment of persistent halogenated xenobiotics in cell culture models. Comparison of mono- and poly-halogenated compounds [An article from: Chemosphere]
by S.F. Muhlebach (Author), G. Karlaganis (Author), U.E. Honegger (Author)


This digital document is a journal article from Chemosphere, published by Elsevier in . The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
We evaluated the suitability of single and multiple cell type cultures as model systems to characterise cellular kinetics of highly lipophilic compounds with potential ecotoxicological impact. Confluent mono-layers of human skin fibroblasts, rat astrocytoma C6 cells, non-differentiated and differentiated mouse 3T3 cells were kept in culture medium supplemented with 10% foetal calf serum. For competitive uptake experiments up to four different cell types, grown on glass sectors, were exposed for 3h to ^1^4C-labelled model...

The persistent nonhealing ulcer: Could it be basal cell carcinoma? (Postgraduate Medicine)

The persistent nonhealing ulcer: Could it be basal cell carcinoma? (Postgraduate Medicine)
by JTE Multimedia


A 76-year-old man presented with a 6-month history of a nonhealing ulcer that appeared on his mid back after trauma to the area. Physical examination revealed a crusted lesion 1 cm in diameter with slight erythema at the base (figure 1). A shave biopsy was obtained. Histologic examination revealed keratotic basal cell carcinoma (figure 2). One week later, electrodesiccation and curettage of the base of the tumor, including the 1.5-mm border, was performed three times. Six months later, there were no signs of recurrence.

Original Publication Date: January 2001

Cell Phone Science: What Happens When You Call and Why (Worlds of Wonder)

Cell Phone Science: What Happens When You Call and Why (Worlds of Wonder)
by Michele Sequeira (Author), Michael Westphal (Author)


Their buzzes, beeps, bells, and tunes have disrupted countless classes, movies, and meals; public auditoriums now have signs posted prominently asking people to turn their cell phones off; cities such as Santa Fe have banned their use in automobiles. But these little connection gadgets have become ubiquitous because they are so useful many would blanch at the thought of losing their cell phone. Cell phones are useful because of the science, technology, and design that are blended to make them function.

In this work, authors Michele Sequeira and Michael Westphal help young people explore this now-commonplace, socially important gadget that connects today s youth with their friends. The underlying science and technologies, and some of the history that has influenced the development...

Tissue Engineering in Regenerative Medicine (Stem Cell Biology and Regenerative Medicine)

Tissue Engineering in Regenerative Medicine (Stem Cell Biology and Regenerative Medicine)
by Harold S. Bernstein (Editor)


Over the past decade, significant advances in the fields of stem cell biology, bioengineering, and animal models have converged on the discipline of regenerative medicine. Significant progress has been made leading from pre-clinical studies through phase 3 clinical trials for some therapies. This volume provides a state-of-the-art report on tissue engineering toward the goals of tissue and organ restoration and regeneration. Examples from different organ systems illustrate progress with growth factors to assist in tissue remodeling; the capacity of stem cells for restoring damaged tissues; novel synthetic biomaterials to facilitate cell therapy; transplantable tissue patches that preserve three-dimensional structure; synthetic organs generated in culture; aspects of the immune response to...

Persistent T-cell activation: A therapeutic option for alopecia areata: Role of Myeloid derived suppressor cells and adhesion molecules in curing alopecia areata

Persistent T-cell activation: A therapeutic option for alopecia areata: Role of Myeloid derived suppressor cells and adhesion molecules in curing alopecia areata
by Vibhuti Singh (Author)


Alopecia areata is a T-cell mediated autoimmune disease which mainly affects the anagen stage hair follicles, the most effective way of treating alopecia areata is the application of contact sensitizers which induces a mild chronic eczema (delayed type hypersensitivity). The curative effect of chronic eczema relies on the expansion of myeloid derived suppressor cells (MDSC) which can suppress the autoreactive T-cells and induces apoptosis of these via mitochondrial apoptotic pathway. Alternatively, a blockade of accessory molecules in T-cell activation could possibly be of therapeutic benefit. CD44 and CD49d being candidate accessory molecules since association of CD44 with CD49d plays an important role in homing of lymphocytes and blockade of these bystander pathways could be a...

Sickle Cell Anemia  : A Mother's Perspective What Every Parent Should Know

Sickle Cell Anemia : A Mother's Perspective What Every Parent Should Know
by Ms. Mercedes Lipscomb (Author), Michael Chamberlin (Editor)


Sickle Cell Anemia: A Mother's Perspective offers information that every parent should know when caring for a child diagnosed with this disease. The goal of this book is to share a firsthand account of some personal situations experienced when interacting with a school district and some medical professionals. I am offering practical tips that may make life a bit easier for parents caring for children diagnosed with sickle cell anemia.

Signaling Networks and Cell Cycle Control : The Molecular Basis of Cancer and Other Diseases (Cancer Drug Discovery and Development, 5) (Cancer Drug Discovery and Development)

Signaling Networks and Cell Cycle Control : The Molecular Basis of Cancer and Other Diseases (Cancer Drug Discovery and Development, 5) (Cancer Drug Discovery and Development)
by J. Silvio Gutkind (Editor)


Leading scientists summarize the latest findings on signal transduction and cell cycle regulation and describe the effort to design and synthesize inhibiting molecules, as well as to evaluate their biochemical and biological activities. They review the relevant cell surface receptors, their ligands, and their downstream pathways. Also examined are the latest findings on the components of novel signaling networks controlling the activity of nuclear transcription factors and cell cycle regulatory molecules. Cutting-edge and highly suggestive, Signaling Networks and Cell Cycle Control: The Molecular Basis of Cancer and Other Diseases presents a wealth of information on the emerging principles of the field, as well as an invaluable guide for all experimental and clinical investigators of cell...

International Review Of Cytology, Volume 258: A Survey of Cell Biology (International Review of Cell and Molecular Biology)

International Review Of Cytology, Volume 258: A Survey of Cell Biology (International Review of Cell and Molecular Biology)
by Kwang W. Jeon (Editor)


International Review of Cytology presents current advances and comprehensive reviews in cell biology - both plant and animal. Authored by some of the foremost scientists in the field, each volume provides up-to-date information and directions for future research. This volume contains articles on Mechanism of Depolymerization and Severing of Actin Filaments and Its Significance in Cytoskeletal Dynamics; Biology of Polycomb and Thrithorax Group Proteins; Cell and Molecular Biology of Transthyretin and Thyroid Hormones; and Development and Role of Tight Junctions in the Retinal Pigment Epithelium.

Neural Cell Behavior and Fuzzy Logic: The Being of Neural Cells and Mathematics of Feeling

Neural Cell Behavior and Fuzzy Logic: The Being of Neural Cells and Mathematics of Feeling
by Uziel Sandler (Author), Lev Tsitolovsky (Author)


This book covers at an advanced level the most fundamental ideas, concepts and methods in the field of applications of fuzzy logic to the study of neural cell behavior. Motivation and awareness are examined from a physiological and biochemical perspective illustrating fuzzy mechanisms of complex systems.

Islet Transplantation and Beta Cell Replacement Therapy

Islet Transplantation and Beta Cell Replacement Therapy
by A.M. James Shapiro (Editor), James A.M. Shaw (Editor)


Beta cell replacement through transplantation remains the only treatment option for Type 1 diabetes enabling restoration of near-physiological glucose levels without significant hypoglycemia. Outlining the most recent advances and research breakthroughs, this practical guide and reference work explores the impact of islet cell transplantation and brings together leading multidisciplinary proponents critical to future success in the field. Edited by a surgeon and an endocrinologist at the forefront of the technology, this volume considers challenges associated with this procedure including lack of sufficient donor organs and the side effects of immunosuppressive therapy, as well as the potential benefits for current and future patients.

corner bottom left corner bottom right
© 2012 BrightSurf.com